Despite failing its primary endpoint in the EMBARK confirmatory study, Elevidys’...
This positive news comes after Otsuka’s Phase III Alzheimer’s agitation trial fa...
Though the designation is for soft tissue sarcoma, tigilanol tiglate is in clini...
Regeneron and Sanofi's Dupixent has been approved for the treatment of chronic s...
A new CDC report shows Lyme disease cases rose by 69% in 2022 over previous year...
A recently unsealed lawsuit claims several large pharma companies that participa...
A new study offers additional evidence that abortion pills are safe to prescribe...
In this edition of STAT's health tech newsletter: Remote Patient Monitoring codi...
IQVIA — a multibillion-dollar firm that sells services to the drug industry — sa...
The U.S. FTC is launching a probe into the extent to which group purchasing orga...
Independent doctors are becoming an endangered species.
How Amylyx Pharmaceuticals could be affected by the impending results of a trial...
New Juul documents give a rare window into the otherwise opaque methods corporat...
The NIH just gave a project to study and test treatments for long Covid a major ...
A leaked version of a deal between the European Free Trade Association and India...
Omar Abudayyeh and Jonathan Gootenberg,have cofounded a gene-editing startup, To...
